LEK Consulting

LEK Consulting, a UK/US firm, has published the results of a global survey aimed at gauging the impact of the proposed US Biosecure Act on life sciences companies. Conducted in June 2024, the survey included a selection of biopharma firms, investors, and CROs/CDMOs. The survey revealed that 68% of respondents…